FDA Approves Controversial Alzheimer ' s Drug FDA Approves Controversial Alzheimer ' s Drug

Disregarding the recommendation from its advisory panel, the FDA has approved the controversial anti-amyloid aducanumab for Alzheimer ' s disease.FDA Approvals
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Neurology & Neurosurgery News Alert Source Type: news